|
1
|
Stupp R, Tonn JC, Brada M and
Pentheroudakis G; ESMO Guidelines Working Group: High-grade
malignant glioma: ESMO Clinical Practice Guidelines for diagnosis,
treatment and follow-up, : Ann Oncol. 21 Suppl:S190–S193. 2010.
View Article : Google Scholar
|
|
2
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen R, Lewis KA, Perrin MH and Vale WW:
Expression cloning of a human corticotropin-releasing-factor
receptor. Proc Natl Acad Sci USA. 90:8967–8971. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perrin M, Donaldson C, Chen R, Blount A,
Berggren T, Bilezikjian L, Sawchenko P and Vale W: Identification
of a second corticotropin-releasing factor receptor gene and
characterization of a cDNA expressed in heart. Proc Natl Acad Sci
USA. 92:2969–2973. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dautzenberg FM and Hauger RL: The CRF
peptide family and their receptors: Yet more partners discovered.
Trends Pharmacol Sci. 23:71–77. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Audhya T, Jain R and Hollander CS:
Receptor-mediated immuno-modulation by corticotropin-releasing
factor. Cell Immunol. 134:77–84. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Clifton VL, Owens PC, Ribinson PJ and
Smith R: Identification and characterization of a
corticotropin-releasing hormone receptor in human placenta. Eur J
Endocrinol. 133:591–597. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roe SY, McGowan EM and Rothwell NJ:
Evidence for the involvement of corticotropin-releasing hormone in
the pathogenesis of traumatic brain injury. Eur J Neurosci.
10:553–559. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Strijbos PJ, Relton JK and Rothwell NJ:
Corticotropinreleasing factor antagonist inhibits neuronal damage
induced by focal cerebral ischaemia or activation of NMDA receptors
in the rat brain. Brain Res. 656:405–408. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lezoualc'h F, Engert S, Berning B and Behl
C: Corticotropinreleasing hormone-mediated neuroprotection against
oxidative stress is associated with the increased release of
non-amyloidogenic amyloid b precursor protein and with the
suppression of nuclear factor-jB. Mol Endocrinol. 14:147–159. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baram TZ and Hatalski CG:
Neuropeptide-mediated excitability: A key triggering mechanism for
seizure generation in the developing brain. Trends Neurosci.
21:471–476. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gutknecht E, Hauger RL, Van der Linden I,
Vauquelin G and Dautzenberg FM: Expression, binding, and signaling
properties of CRF2 (a) receptors endogenously expressed in human
retinoblastoma Y79 cells: Passage-dependent regulation of
functional receptors. J Neurochem. 104:926–936. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schoeffter P, Feuerbach D, Bobirnac I,
Gazi L and Longato R: Functional, endogenously expressed
corticotropin-releasing factor receptor type 1 (CRF1) and CRF1
receptor mRNA expression in human neuroblastoma SH-SY5Y cells.
Fundam Clin Pharmacol. 13:484–489. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sato H, Nagashima Y, Chrousos GP,
Ichihashi M and Funasak Y: The expression of
corticotropin-releasing hormone in melanoma. Pigment Cell Res.
15:98–103. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Funasaka Y, Sato H, Chakraborty AK, Ohashi
A, Chrousos GP and Ichihashi M: Expression of proopiomelanocortin,
corticotropinreleasing hormone (CRH), and CRH receptor in melanoma
cells, nevus cells, and normal human melanocytes. J Investig
Dermatol Symp Proc. 4:105–109. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Graziani G, Tentori L, Muzi A, Vergati M,
Tringali G, Pozzoli G and Navarra P: Evidence that
corticotropin-releasing hormone inhibits cell growth of human
breast cancer cells via the activation of CRH-R1 receptor subtype.
Mol Cell Endocrinol. 264:44–49. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Moliterno JA, Henry E and Pannullo SC:
Corticorelin acetate injections for the treatment of peritumoral
brain edema. Expert Opin Investig Drugs. 18:1413–1419. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Muleci A, Cervoni L and Delfini R:
Medulloblastomas in children and in adults:a comparative study.
Acta Neurochir (Wien). 119:62–67. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roberts RO, Lynch CF, Jones MP and Hart
MN: Medulloblastoma: A population-based study of 532 cases. J
Neuropathol Exp Neurol. 50:134–144. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarkar C, Pramanik P, Karak AK,
Mukhopadhyay P, Sharma MC, Singh VP and Mehta VS: Are childhood and
adult medulloblastomas different? A comparative study of
clinicopathological features, proliferation index and apoptotic
index. J Neurooncol. 59:49–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hao J, Wang Z, Wang Y, Liang Z, Zhang X,
Zhao Z and Jiao B: Eukaryotic initiation factor 3C silencing
inhibits cell proliferation and promotes apoptosis in human glioma.
Oncol Rep. 33:2954–2962. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2 (-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohgaki H and Kleihues P: Epidemiology and
etiology of gliomas. Acta Neuropathol. 109:93–108. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Graziani G, Tentori L, Portarena I,
Barbarino M, Tringali G, Pozzoli G and Navarra P: CRH inhibits cell
growth of human endometrial adenocarcinoma cells via CRH-receptor
1-mediated activation of cAMP-PKA pathway. Endocrinology.
143:807–813. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Grigoriadis DE, Lovenberg TW, Chalmers DT,
Liaw C and De Souze EB: Characterization of corticotropin-releasing
factor receptor subtypes. Ann N Y Acad Sci. 780:60–80. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bayatti N, Zschocke J and Behl C: Brain
region-specific neuroprotective action and signaling of
corticotropin-releasing hormone in primary neurons. Endocrinology.
144:4051–4060. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Carlson KW, Nawy SS, Wei ET, Sadee W,
Filov VA, Rezsova VV, Slominski A and Quillan JM: Inhibition of
mouse melanoma cell proliferation by corticotropin-releasing
hormone and its analogs. Anticancer Res. 21:1173–1179.
2001.PubMed/NCBI
|
|
29
|
Moroz MA, Huang R, Kochetkow T, Shi W,
Thaler H, de Stanchina E, Gamez I, Ryan RP and Blasberg RG:
Comparison of corticotropin- releasing factor, dexamethasone, and
temozolomide: Treatment efficacy and toxicity in U87 and C6
intracranial gliomas. Clin Cancer Res. 17:3282–3292. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YJ, Chung DY, Lee SJ, Jhon Ja G and
Lee YS: Enhanced radiosensitization of p53 mutant cells by
oleamide. Int J Radiat Oncol Biol Phys. 64:1466–1474. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ohgaki H, Dessen P, Jourde B, Horstmann S,
Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM,
Maiorka PC, et al: Genetic pathways to glioblastoma: A
population-based study. Cancer Res. 64:6892–6899. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu LX, Li ZH, Tao YF, Li RH, Fang F, Zhao
H, Li G, Li YH, Wang J, Feng X and Pan J: Histone acetyltransferase
inhibitor II induces apoptosis in glioma cell lines via the p53
signaling pathway. J Exp Clin Cancer Research. 33:1082014.
View Article : Google Scholar
|
|
33
|
Zhao Y, Wang MY, Hao K, Chen XQ and Du JZ:
CRHR1 mediates p53 transcription induced by high altitude hypoxia
through ERK 1/2 signaling in rat hepatic cells. Peptides. 44:8–14.
2013. View Article : Google Scholar : PubMed/NCBI
|
